Know everything about our services

As medical devices and pharmaceutical products move into industrial production, sterilization becomes a recurring part of the manufacturing process. Alongside quality, capacity and turnaround time, manufacturers are increasingly looking for greater visibility into the environmental impact associated with their production activities.

Sterilization requirements should be considered early in the development of medical devices and pharmaceutical products. Materials, product design, packaging configuration and process conditions can influence the suitability of a sterilization method and the subsequent validation strategy.

As medical devices continue to evolve in complexity and innovation, sterilization strategies are increasingly being tailored to individual product characteristics. Device geometry, material composition, packaging systems, and load configurations all influence sterilization performance and contribute to the development of robust, product-specific processes.

For medical devices and pharmaceutical products marketed as sterile, sterilization validation represents a critical transition point between development and routine commercial manufacturing. At this stage, manufacturers must demonstrate that the finalized product, packaging system, and manufacturing configuration can be sterilized under controlled and reproducible conditions while maintaining product performance and compliance with regulatory requirements.

Sterilization processes are often associated with standardized cycle recipes designed to treat a broad range of healthcare products. In practice, however, many medical devices, pharmaceutical components, and packaging systems require sterilization conditions that cannot be reliably addressed using predefined cycle parameters.

As medical devices and pharmaceutical products transition into the industrialization phase, manufacturing activities evolve from development-driven execution to stable, repeatable production under controlled conditions.

At Medistri, we recognize that terminal sterilisation is a critical process step requiring uncompromising assurance while preserving the integrity and performance of medical devices. Our EO sterilization services are designed to integrate into your development and manufacturing operations, delivering controlled, validated, and traceable processes aligned with regulatory expectations.

EO is a well-established low-temperature sterilization process widely used across the medical device and pharmaceutical industries. While EO Sterilization and EO Treatment are sometimes used interchangeably, they represent two fundamentally different approaches with important quality, validation, and regulatory implications.

Selecting the appropriate sterilization approach begins with understanding how different products behave under exposure. A single load cycle is designed to sterilize products that share comparable material properties, packaging configurations, geometry, and sterilization requirements.

At Medistri, sustainability is managed through measurable data and verified processes. Across our sterilization, laboratory, and logistics operations, environmental performance is continuously monitored to identify opportunities for greater efficiency and emission reduction.